November 9-11, 2020 | Virtual Conference

Speakers

Edwin Jao, PhD

Director, Division of Pharmaceutical Manufacturing Assessment 3, Office of Pharmaceutical Manufacturing Assessment (OPMA), OPQ, CDER
FDA

Edwin Jao is the division director for FDA/CDER/Office of Product Quality (OPQ)/Office of Pharmaceutical Assessment (OPMA), overseeing process and facility reviews for ANDAs, NDAs, and IND meeting packages. He joined the FDA in 2003 as a CMC reviewer, after a career in major pharmaceutical industries with increased responsibilities. Edwin received his Ph.D. degree in medicinal chemistry from Rutgers University.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Skip to content